Literature DB >> 1671434

Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICBERG (International Community-based Epilepsy Research Group)

A T Feksi1, J Kaamugisha, J W Sander, S Gatiti, S D Shorvon.   

Abstract

A programme of antiepileptic treatment in a rural and semi-urban region in Kenya was assessed. Patients with generalised tonic-clonic seizures were treated according to one of two simple drug protocols. Health workers screened cases reported by key informants in the community. From the 529 patients identified by health workers as having active seizures 302 patients aged 6-65 years were recruited by a psychiatrist for therapy with carbamazepine or phenobarbitone. Treatment was supervised largely by primary health workers, and the programme was monitored by a research team, which assessed the effectiveness of treatment. Of the 249 patients who completed the study, 53% became seizure-free in the second 6 months of therapy, and another 26% had substantially (50% or more reduction) fewer seizures than in the 6 months before therapy. The similarity of these findings to those obtained in newly diagnosed patients in the developed world, the low drop-out rate, the low rate of withdrawal due to adverse effects, and the acceptable compliance with therapy indicate that health workers can monitor therapy adequately. Most patients had had several years of delay before starting therapy for their epilepsy, yet they responded well--a finding that does not support the suggestion that the disorder becomes intractable if not treated early.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671434     DOI: 10.1016/0140-6736(91)91176-u

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  35 in total

1.  Pros and cons for the development of new antiepileptic drugs.

Authors:  Meir Bialer; Matthew C Walker; Josemir W Sander
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Developing effective chronic disease interventions in Africa: insights from Ghana and Cameroon.

Authors:  Ama de-Graft Aikins; Petra Boynton; Lem L Atanga
Journal:  Global Health       Date:  2010-04-19       Impact factor: 4.185

3.  Revisiting phenobarbital for epilepsy.

Authors:  Rajendra Kale; Emilio Perucca
Journal:  BMJ       Date:  2004-11-20

4.  Treatment of epilepsy in developing countries.

Authors:  Emilio Perucca
Journal:  BMJ       Date:  2007-06-09

Review 5.  Drug treatment of epilepsy in the 1990s. Achievements and new developments.

Authors:  A Sabers; L Gram
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

Review 6.  Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.

Authors:  Sarah J Nevitt; Maria Sudell; Jennifer Weston; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2017-06-29

Review 7.  Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nolan; Anthony G Marson; Jennifer Weston; Catrin Tudur Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-12-15

Review 8.  Treatment strategies after a single seizure : rationale for immediate versus deferred treatment.

Authors:  Laura C Miller; Frank W Drislane
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 9.  Challenges in the management of epilepsy in resource-poor countries.

Authors:  Kurupath Radhakrishnan
Journal:  Nat Rev Neurol       Date:  2009-05-19       Impact factor: 42.937

10.  Childhood epilepsy: Management in resource-limited setting.

Authors:  Chhaya Valvi; Subhashchandra Daga; Ujwala Kabade; Madhuri Agarwal
Journal:  Ann Indian Acad Neurol       Date:  2008-01       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.